RENAL IRRITATION AGAINST THE BACKGROUND OF INTOXICATION OF SALTS OF HEAVY METALS


Cite item

Full Text

Abstract

Details of pathogenesis, clinical presentation, diagnosis and treatment of nephropathies, induced by lead, cadmium and mercury intoxicationm are discussed.

About the authors

- -

References

  1. Мухин Н.А., Балкаров И.М., Моисеев С.В. и др. Хронические прогрессирующие нефропатии и образ жизни современного человека. Тер. арх. 2004; 5 - 9.
  2. Wedeen R.P. Occupational and environmental renal disease. Semin. Nephrol. 1997; 17(1): 46 - 53.
  3. Jarup L., Alfven T. Low level cadmium exposure, renal and bone effects--the OSCAR study. Biometals. 2004; 17(5): 505 - 509.
  4. Uetani M., Kobayashi E., Suwazono Y. et al. Investigation of renal damage among residents in the cadmium-polluted Jinzu River basin, based on health examinations in 1967 and 1968. Int. J. Environ. Health Res. 2007; 17(3): 231 - 242.
  5. Jarup L. Cadmium overload and toxicity. Nephrol. Dial Transplant. 2002; 17(Suppl. 2): 35 - 39.
  6. Franko A., Budihna M.V., Dodic-Fikfak M. Long-term effects of elemental mercury on renal function in miners of the Idrija Mercury Mine. Ann. Occup. Hyg. 2005; 49(6): 521 - 527.
  7. Sabolic I. Common mechanisms in nephropathy induced by toxic metals. Nephron Physiol. 2006; 104(3): p107 - p114.
  8. Ekong E.B., Jaar B.G., Weaver V.M. Lead-related nephrotoxicity: a review of the epidemiologic evidence. Kidney Int. 2006; 70(12): 2074 - 2084.
  9. Dunbabin D.W., Tallis G.A., Popplewell P.Y. et al. Lead poisoning from Indian herbal medicine (Ayurveda). Med. J. Aust. 1992; 157(11-12): 835 - 836.
  10. Roche A., Florkowski C., Walmsley T. Lead poisoning due to ingestion of Indian herbal remedies. N. Z. Med. J. 2005; 118(1219): U1587.
  11. Prakash S., Hernandez G.T., Dujaili I. et al. Lead poisoning from an Ayurvedic herbal medicine in a patient with chronic kidney disease. Nat. Rev. Nephrol. 2009; 5(5): 297 - 300.
  12. Gidlow D.A. Lead toxicity. Occup. Med. (Lond). 2004; 54(2): 76 - 81.
  13. Tubbs R.R., Gephardt G.N., McMahon J.T. et al. Membranous glomerulonephritis associated with industrial mercury exposure. Study of pathogenetic mechanisms. Am. J. Clin. Pathol. 1982; 77(4): 409 - 413.
  14. Лебедева М.В., Балкаров И.М., Шовская Т.Н. и др. Свинцовая подагра. Клин. мед. 1995; 3: 103 - 104.
  15. Nordberg G.F. Historical perspectives on cadmium toxicology. Toxicol. Appl. Pharmacol. 2009; 238(3): 192 - 200.
  16. Batuman V. Lead nephropathy, gout, and hypertension. Am. J. Med. Sci. 1993; 305(4): 241 - 247.
  17. Langford N., Ferner R. Toxicity of mercury. J. Hum. Hypertens. 1999; 13(10): 651 - 656.
  18. Lin-Tan D.T., Lin J.L., Yen T.H. et al. Long-term outcome of repeated lead chelation therapy in progressive non-diabetic chronic kidney diseases. Nephrol. Dial. Transplant. 2007; 22(10): 2924 - 2931.
  19. Lin J.L., Lin-Tan D.T., Li Y.J. et al. Low-level environmental exposure to lead and progressive chronic kidney diseases. Am. J. Med. 2006; 119(8): 707.e1 - e9.
  20. Lin J.L., Lin-Tan D.T., Hsu K.H. et al. Environmental lead exposure and progression of chronic renal diseases in patients without diabetes. N. Engl. J. Med. 2003; 348(4): 277 - 286.
  21. Goyer R.A. Lead toxicity: current concerns. Environ. Health. Perspect. 1993; 100: 177 - 187.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies